In‐Depth Optimization and Systematic Evaluation of a Recombinant AAV ‐Based Hepatic‐Targeted Gene Knockdown Murine Model
The FASEB Journal · 2025
DOI: 10.1096/fj.202502602r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Ying Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: Dependovirus, Liver, Gene Knockdown Techniques, Genetic Vectors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Hepatobiliary Care Foundation of Henan Charity General Federation, College Science and Technology Innovation Team of Henan Province.
Abstract (Originalsprache)
Precise gene‐edited animal models are essential for preclinical liver research but are typically time‐consuming and costly. Here, a liver‐specific knockdown mouse model was developed based on a recombinant AAV (rAAV) tool, which is rapid and economical, with optimized delivery methods and systematically evaluated knockdown efficiency. Hepatic ischemia/reperfusion (IR) injury‐related genes ( Btg2 , Flrt3 , Klf4 ) were screened through GEO data mining. To knock down these genes, rAAV vectors featuring a liver‐specific promoter TBG669, Firefly luciferase (Fluc) for real‐time tracking, and miR30‐based regulatory elements were engineered. Delivery protocols were optimized through comparative analysis of reporting systems (GFP vs. Fluc), administration routes (tail vein vs. dorsal penile vein), and doses (half [2.5 × 10 11 GC] vs. full dose [5.0 × 10 11 GC]). Safety and knockdown efficiency were systematically assessed using histopathology, serum biochemistry, qRT‐PCR, and western blot analysis both in bulk liver tissue and single‐cell subsets. The optimized rAAV system achieved 100% hepatic infection rates with minimal off‐target expression. Dorsal penile vein injection simplified delivery without compromising efficacy. Full‐dose administration produced stronger bioluminescence by Week 4, with no adverse effects on organ function or histology. For knockdown efficiencies, Btg2 and Flrt3 mRNA and protein levels were reduced by > 50%, whereas Klf4 exhibited moderate suppression in bulk liver tissue. In single‐cell subsets, the three genes were all effectively knocked down in Kupffer cells, followed by hepatocytes and LSECs. A time‐ and cost‐efficient rAAV‐based hepatic gene knockdown murine model was established, enabling precise investigation of liver disease mechanisms and therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Henan Key Laboratory for Hepatopathy and Transplantation Medicine, Zhengzhou, Henan, China.
- Henan Key Laboratory of Digestive Organ Transplantation, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Department of Surgical Intensive Care Unit, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Department of Hepatic Surgery and Liver Transplantation Center, the Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
- School of Basic Medical Sciences, Lanzhou University, Lanzhou, Gansu, China.
ORCID-Profile: Wenzhi Guo, Lele Zhang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Hepatobiliary Care Foundation of Henan Charity General Federation
- College Science and Technology Innovation Team of Henan Province
- Scientific Research and Innovation Team of The First Affiliated Hospital of Zhengzhou University
- Young Talent Support Program of Henan Association for Science and Technology
- Henan Provincial Medical Science and Technology Research Project
- Natural Science Foundation of Henan Province
- National Natural Science Foundation of China
Zitieren
APA
Zhu, Y., You, G., Jiang, Y., Yin, K., Wang, R., Li, C., Zhang, X., Yan, Z., Ding, M., Guo, W., & Zhang, L. (2025). In‐Depth Optimization and Systematic Evaluation of a Recombinant AAV ‐Based Hepatic‐Targeted Gene Knockdown Murine Model. The FASEB Journal. https://doi.org/10.1096/fj.202502602r
Vancouver
Zhu Y, You G, Jiang Y, Yin K, Wang R, Li C, et al. In‐Depth Optimization and Systematic Evaluation of a Recombinant AAV ‐Based Hepatic‐Targeted Gene Knockdown Murine Model. The FASEB Journal. 2025. doi:10.1096/fj.202502602r
BibTeX
@article{Zhu2025,
author = {Zhu, Ying and You, Guohua and Jiang, Yong and Yin, Keyu and Wang, Rui and Li, Changhong and Zhang, Xiaodan and Yan, Zhiping and Ding, Mingjie and Guo, Wenzhi and Zhang, Lele},
title = {In‐Depth Optimization and Systematic Evaluation of a Recombinant AAV ‐Based Hepatic‐Targeted Gene Knockdown Murine Model},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202502602r}
}
EUVIMED